166 related articles for article (PubMed ID: 10064182)
1. Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia.
Leahey AM; Teunissen H; Friedman DL; Moshang T; Lange BJ; Meadows AT
Med Pediatr Oncol; 1999 Mar; 32(3):163-9. PubMed ID: 10064182
[TBL] [Abstract][Full Text] [Related]
2. Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood.
Liesner RJ; Leiper AD; Hann IM; Chessells JM
J Clin Oncol; 1994 May; 12(5):916-24. PubMed ID: 8164042
[TBL] [Abstract][Full Text] [Related]
3. Growth in children after bone marrow transplantation for acute leukemia.
Huma Z; Boulad F; Black P; Heller G; Sklar C
Blood; 1995 Jul; 86(2):819-24. PubMed ID: 7606013
[TBL] [Abstract][Full Text] [Related]
4. Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia.
Hasle H; Kerndrup G; Yssing M; Clausen N; Ostergaard E; Jacobsen N; Jacobsen BB
Leukemia; 1996 Aug; 10(8):1269-73. PubMed ID: 8709630
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
[TBL] [Abstract][Full Text] [Related]
7. High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group.
Brown RA; Wolff SN; Fay JW; Pineiro L; Collins RH; Lynch JP; Stevens D; Greer J; Herzig RH; Herzig GP
Leuk Lymphoma; 1996 Jul; 22(3-4):271-7. PubMed ID: 8819076
[TBL] [Abstract][Full Text] [Related]
8. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study.
Woods WG; Kobrinsky N; Buckley J; Neudorf S; Sanders J; Miller L; Barnard D; Benjamin D; DeSwarte J; Kalousek D
J Clin Oncol; 1993 Aug; 11(8):1448-57. PubMed ID: 8336184
[TBL] [Abstract][Full Text] [Related]
9. High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group.
Brown RA; Wolff SN; Fay JW; Pineiro L; Collins RH; Lynch JP; Stevens D; Greer J; Herzig RH; Herzig GP
Blood; 1995 Mar; 85(5):1391-5. PubMed ID: 7858269
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of chemotherapy alone with allogeneic bone marrow transplantation in first full remission in children with acute myeloid leukemia in the AML-BFM-83 and AML-BFM-87 studies--matched pair analysis].
Creutzig U; Bender-Götze C; Klingebiel T; Ebell W; Friedrich W; Stollmann-Gibbels B; Schmidt H; Suttorp M; Gratwohl A; Heyen P
Klin Padiatr; 1992; 204(4):246-52. PubMed ID: 1518260
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation.
Sierra J; Brunet S; Grañena A; Olivé T; Bueno J; Ribera JM; Petit J; Besses C; Llorente A; Guardia R; Macía J; Rovira M; Badell I; Vela E; Díaz de Heredia C; Vivancos P; Carreras E; Feliu E; Montserrat E; Julía A; Cubells J; Rozman C; Domingo A; Ortega JJ
J Clin Oncol; 1996 Apr; 14(4):1353-63. PubMed ID: 8648394
[TBL] [Abstract][Full Text] [Related]
12. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties.
Burnett AK; Goldstone AH; Stevens RM; Hann IM; Rees JK; Gray RG; Wheatley K
Lancet; 1998 Mar; 351(9104):700-8. PubMed ID: 9504514
[TBL] [Abstract][Full Text] [Related]
13. [Allogeneic bone marrow transplantation for two patients with acute myeloid leukemia with trilineage myelodysplasia (T-MDS)].
Fukushima T; Kuriyama K; Yoshida S; Nagai K; Miyazaki Y; Moriuti Y; Tomonaga M
Rinsho Ketsueki; 1994 Feb; 35(2):171-6. PubMed ID: 8139116
[TBL] [Abstract][Full Text] [Related]
14. Late effects of treatment in survivors of childhood acute myeloid leukemia.
Leung W; Hudson MM; Strickland DK; Phipps S; Srivastava DK; Ribeiro RC; Rubnitz JE; Sandlund JT; Kun LE; Bowman LC; Razzouk BI; Mathew P; Shearer P; Evans WE; Pui CH
J Clin Oncol; 2000 Sep; 18(18):3273-9. PubMed ID: 10986060
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic bone marrow transplantation improves the outcome of de novo AML with trilineage dysplasia (AML-TLD).
Taguchi J; Miyazaki Y; Yoshida S; Fukushima T; Moriuchi Y; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M
Leukemia; 2000 Nov; 14(11):1861-6. PubMed ID: 11069020
[TBL] [Abstract][Full Text] [Related]
16. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.
Michel G; Socié G; Gebhard F; Bernaudin F; Thuret I; Vannier JP; Demeocq F; Leverger G; Pico JL; Rubie H; Mechinaud F; Reiffers J; Gratecos N; Troussard X; Jouet JP; Simonin G; Gluckman E; Maraninchi D
J Clin Oncol; 1997 Jun; 15(6):2238-46. PubMed ID: 9196136
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
18. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.
Stevens RF; Hann IM; Wheatley K; Gray RG
Br J Haematol; 1998 Apr; 101(1):130-40. PubMed ID: 9576193
[TBL] [Abstract][Full Text] [Related]
19. Engraftment following mitoxantrone (Mito) based conditioning for allogeneic bone marrow transplantation (allo-BMT).
Nagler A; Soni S; Samuel S; Or R
Leuk Res; 1998 Mar; 22(3):209-13. PubMed ID: 9619912
[TBL] [Abstract][Full Text] [Related]
20. Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891.
Lange BJ; Kobrinsky N; Barnard DR; Arthur DC; Buckley JD; Howells WB; Gold S; Sanders J; Neudorf S; Smith FO; Woods WG
Blood; 1998 Jan; 91(2):608-15. PubMed ID: 9427716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
